4,966
Views
27
CrossRef citations to date
0
Altmetric
Coronaviruses

Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques

, , , , , , & show all
Pages 439-442 | Received 20 Dec 2021, Accepted 12 Jan 2022, Published online: 29 Jan 2022

Figures & data

Figure 1. Safety and immunogenicity of aerosol Ad5-nCoV. (A) Biodistribution of Ad5-nCoV in the tested organs collected on 31 and 42 DPI. The viral genome in the tissues was assessed with qRT-PCR. (B) Ad5-nCoV presence in the blood at the indicated time points. (C and D) S-specific humoral immune responses in serum and bronchoalveolar lavage. (E and F) Pseudovirus neutralization antibody (PNAb) titres for SARS-CoV-2 WT or Delta variant were elevated in blood and BLA, respectively. ****P < 0.0001, ***P < 0.001.

Figure 1. Safety and immunogenicity of aerosol Ad5-nCoV. (A) Biodistribution of Ad5-nCoV in the tested organs collected on 31 and 42 DPI. The viral genome in the tissues was assessed with qRT-PCR. (B) Ad5-nCoV presence in the blood at the indicated time points. (C and D) S-specific humoral immune responses in serum and bronchoalveolar lavage. (E and F) Pseudovirus neutralization antibody (PNAb) titres for SARS-CoV-2 WT or Delta variant were elevated in blood and BLA, respectively. ****P < 0.0001, ***P < 0.001.
Supplemental material

Supplemental Material

Download Zip (5.6 MB)